Company Filing History:
Years Active: 2010-2022
Title: Innovations and Contributions of Inventor Jen-Wei Chen
Introduction
Jen-Wei Chen is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of methods and formulations that address health issues such as arthritis and wound healing. With a total of four patents to his name, Chen's work exemplifies the intersection of scientific research and practical application.
Latest Patents
One of Chen's latest patents is a method for preparing a fraction having anti-arthritis activity. This invention provides an extract of *Lour.* Spreng that enriches anti-arthritis activity, obtained by eluting the crude extract using a 50% to 95% alcoholic solution or solvents such as hexane and/or ethyl acetate. Additionally, the patent includes a method for treating arthritis using this extract. Another significant patent is a topical formulation for promoting wound healing. This formulation comprises an active agent that includes salvigenin and optionally asiaticoside. The invention also relates to the use of this topical formulation for enhancing wound healing.
Career Highlights
Throughout his career, Jen-Wei Chen has worked with various organizations, including Oneness Biotech Co. and the Medical and Pharmaceutical Industry Technology and Development Center. His experience in these companies has allowed him to apply his innovative ideas in practical settings, contributing to advancements in medical technology.
Collaborations
Chen has collaborated with notable colleagues in his field, including Feng-Nien Ko and Mo-Chi Cheng. These partnerships have likely facilitated the exchange of ideas and fostered innovation in their respective projects.
Conclusion
Jen-Wei Chen's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the fields of health and medicine, showcasing the importance of innovation in addressing real-world challenges.